The Influence of Substance Use on Traumatic Brain Injury Recovery and Rehabilitation Outcomes: The Outcome-ABI Study.


Journal

Archives of physical medicine and rehabilitation
ISSN: 1532-821X
Titre abrégé: Arch Phys Med Rehabil
Pays: United States
ID NLM: 2985158R

Informations de publication

Date de publication:
07 2023
Historique:
received: 22 08 2022
revised: 05 03 2023
accepted: 14 03 2023
medline: 7 7 2023
pubmed: 7 4 2023
entrez: 6 4 2023
Statut: ppublish

Résumé

This study characterized substance use (alcohol, illicit drugs, amphetamines) in patients with traumatic brain injury (TBI) receiving rehabilitation to determine potential benefit of rehabilitation and whether substance use influenced outcomes in moderate-severe TBI. Prospective, longitudinal study of adults with moderate or severe TBI receiving inpatient rehabilitation. Specialist-staffed acquired brain injury rehabilitation center in Melbourne, Australia. A total of 153 consecutive inpatients with TBI admitted between January 2016 and December 2017 (24 months). All inpatients with TBI (n=153) received specialist-provided brain injury rehabilitation in accordance with evidence-based guideline care at one 42-bed rehabilitation center. Data were collected at time of TBI, upon rehabilitation admission, and discharge and 12 months' post-TBI. Recovery was measured by posttraumatic amnesia posttraumatic amnesia length-days and change in Glasgow Coma Scale (admission-discharge). Functional independence was measured on the FIM, Functional Assessment Measure, and Mayo Portland Adaptability Index. Quality of life (QOL) was measured on the EuroQOL-5D-5L and Quality of Life After Brain Injury (QOLIBRI) instruments. Inpatients with history of illicit drug use (n=54) reported lower QOL and adjustment at 12 months' post-TBI compared with those with no history (QOLIBRI social relationships: ratio of means=0.808, P=.028; Mayo Portland Adaptability Index adjustment: incidence rate ratio, 1.273; P=.032). Amphetamine use at time of injury (n=10) was associated with quicker recovery (posttraumatic amnesia length-days: incidence rate ratio, 0.173; P<.01); however, lower QOL at 12 months post-TBI was noted in those with a history of amphetamine use (n=34) compared with those without (QOLIBRI bothered feelings: ratio of means, 0.489, P=.036). All participants made improvements with rehabilitation post-TBI; however, a history of substance use was associated with lower reported 12-month QOL. These findings add insight to the associations between substance use and acute recovery, potentially suggestive of a short-term recovery-promoting effect of amphetamines but highlighting the importance of rehabilitation to address long-term sequalae.

Identifiants

pubmed: 37024005
pii: S0003-9993(23)00184-3
doi: 10.1016/j.apmr.2023.03.015
pii:
doi:

Substances chimiques

Amphetamine CK833KGX7E

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1115-1123

Informations de copyright

Copyright © 2023 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Eric Xie (E)

Department of Neurology, Alfred Health, Melbourne, Australia.

Michael Pellegrini (M)

Department of Neuroscience, Central Clinical School, Faculty of Medicine Nursing and Health Science, Monash University, The Alfred Centre, Melbourne, Australia.

Zhibin Chen (Z)

Department of Neuroscience, Central Clinical School, Faculty of Medicine Nursing and Health Science, Monash University, The Alfred Centre, Melbourne, Australia.

Laura Jolliff (L)

Frankston Hospital, Peninsula Health, Frankston, Australia; Peninsula Clinical School, Faculty of Medicine, Nursing and Health Science, Monash University, Frankston, Australia; Department of Occupational Therapy, School of Primary and Allied Health Care, Faculty of Medicine, Nursing and Health Science, Monash University, Frankston, Australia.

Maria Crotty (M)

Rehabilitation and Aged Care, School of Medicine, Flinders University, Adelaide, Australia.

Julie Ratcliffe (J)

Caring Futures Institute, Flinders University, Bedford Park, Adelaide, South Australia.

Jacqui Morarty (J)

Rehabilitation Services, Alfred Health, Melbourne, Australia.

Terence J O'Brien (TJ)

Department of Neurology, Alfred Health, Melbourne, Australia; Department of Neuroscience, Central Clinical School, Faculty of Medicine Nursing and Health Science, Monash University, The Alfred Centre, Melbourne, Australia; Department of Medicine and Neurology, The Royal Melbourne Hospital, Melbourne Health, Parkville, Australia.

Natasha A Lannin (NA)

Department of Neuroscience, Central Clinical School, Faculty of Medicine Nursing and Health Science, Monash University, The Alfred Centre, Melbourne, Australia; Rehabilitation Services, Alfred Health, Melbourne, Australia. Electronic address: natasha.lannin@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH